• <input id="ycg2u"></input>
    <legend id="ycg2u"></legend>
    <strong id="ycg2u"><u id="ycg2u"></u></strong>
  • Enable Accessibility Enable Accessibility

    Enhancing National Laboratories’ Diagnostic Capabilities

    Testing can be available when and where people need it

    The Program



    PartnerInternational Atomic Energy Agency (IAEA)
    Budget500 million yen
    TermCOVID-19 Emergency Response

    IAEA Website

    Over 280 national-designated laboratories for COVID-19 in 127 countries and territories around the world have requested and are receiving the Agency’s assistance and demand is still increasing. The IAEA - Takeda partnership helps the IAEA to continue providing emergency assistance in the form of diagnostic kits, equipment and technical advice and guidance to help rapidly and accurately detect and identify the novel coronavirus that causes COVID-19.

    IAEA’s emergency assistance package includes a real-time RT-PCR diagnostic machine, biosafety cabinets and equipment for sampling, testing, quality control as well as personal protection to run 2,000 tests. Additional support refers to the guidance and provision of standard operating procedures to identify the virus, following the World Health Organization recommendations.



    The pictures above show countries that received IAEA COVID-19 assistance supported by Takeda.

    Stories of Impact

    See how Takeda’s partnership with IAEA is helping 36 laboratories in 26 countries reach 72,000 people with safe, reliable, and rapid COVID-19 diagnosis and critical safety, testing, and quality control equipment in this video.


    Related Content